Wasmuth JC - Search Results

1

Liver fibrosis progression after acute hepatitis C virus infection in HIV-positive individuals.

Vogel M, Page E, Boesecke C, Reiberger T, Schwarze-Zander C, Mauss S, Baumgarten A, Wasmuth JC, Nelson M, Rockstroh JK; European AIDS Treatment Network (NEAT) Study Group. Vogel M, et al. Among authors: wasmuth jc. Clin Infect Dis. 2012 Feb 15;54(4):556-9. doi: 10.1093/cid/cir854. Epub 2011 Dec 7. Clin Infect Dis. 2012. PMID: 22156856

2

Long-term efficacy and safety of ritonavir/indinavir at 400/400 mg twice a day in combination with two nucleoside reverse transcriptase inhibitors as first line antiretroviral therapy.

Lichterfeld M, Nischalke HD, Bergmann F, Wiesel W, Rieke A, Theisen A, Fätkenheuer G, Oette M, Carls H, Fenske S, Nadler M, Knechten H, Wasmuth JC, Rockstroh JK. Lichterfeld M, et al. Among authors: wasmuth jc. HIV Med. 2002 Jan;3(1):37-43. doi: 10.1046/j.1464-2662.2001.00091.x. HIV Med. 2002. PMID: 12059949 Free article. Clinical Trial.

3

First-line ritonavir/indinavir 100/800 mg twice daily plus nucleoside reverse transcriptase inhibitors in a German multicentre study: 48-week results.

Voigt E, Wickesberg A, Wasmuth JC, Gute P, Locher L, Salzberger B, Wöhrmann A, Adam A, Weitner L, Rockstroh JK. Voigt E, et al. Among authors: wasmuth jc. HIV Med. 2002 Oct;3(4):277-82. doi: 10.1046/j.1468-1293.2002.00123.x. HIV Med. 2002. PMID: 12444946 Free article. Clinical Trial.

4

Enteric dysfunction in patients with asymptomatic HIV-infection versus patients with hypoproteinemia/hypalbuminemia and advanced HIV-infection.

Wasmuth JC, Schliefer K, Scheurlen C, Sudhop T, Rockstroh JK, Sauerbruch T, Spengler U. Wasmuth JC, et al. Eur J Med Res. 2002 Dec 17;7(12):536-42. Eur J Med Res. 2002. PMID: 12527499

5

Changes of lymphocyte apoptosis associated with sequential introduction of highly active antiretroviral therapy.

Wasmuth JC, Hackbarth F, Rockstroh JK, Sauerbruch T, Spengler U. Wasmuth JC, et al. HIV Med. 2003 Apr;4(2):111-9. doi: 10.1046/j.1468-1293.2003.00145.x. HIV Med. 2003. PMID: 12702131 Free article.

6

Safety, efficacy and development of resistance under the new protease inhibitor lopinavir/ritonavir: 48-week results.

Voigt E, Wasmuth JC, Vogel M, Mauss S, Schmutz G, Kaiser R, Rockstroh JK. Voigt E, et al. Among authors: wasmuth jc. Infection. 2004 Apr;32(2):82-8. doi: 10.1007/s15010-004-3059-3. Infection. 2004. PMID: 15057572 Clinical Trial.

7

[HIV-infection].

Wasmuth JC, Rockstroh JK. Wasmuth JC, et al. Dtsch Med Wochenschr. 2007 Mar 30;132(13):673-83; quiz 685-6. doi: 10.1055/s-2007-973602. Dtsch Med Wochenschr. 2007. PMID: 17377882 Review. German. No abstract available.

8

Repeated HCV-clearance in an HIV-infected patient.

Vogel M, Wasmuth JC, Rockstroh JK, Holm S, Kuhlmann B. Vogel M, et al. Among authors: wasmuth jc. Infection. 2007 Apr;35(2):120-1. doi: 10.1007/s15010-007-6053-8. Infection. 2007. PMID: 17401720 No abstract available.

9

Maintenance of indinavir by dose adjustment in HIV-1-infected patients with indinavir-related toxicity.

Wasmuth JC, Lambertz I, Voigt E, Vogel M, Hoffmann C, Burger D, Rockstroh JK. Wasmuth JC, et al. Eur J Clin Pharmacol. 2007 Oct;63(10):901-8. doi: 10.1007/s00228-007-0343-z. Epub 2007 Aug 10. Eur J Clin Pharmacol. 2007. PMID: 17690876 Clinical Trial.

10

Comparison of indinavir + ritonavir 600 + 100 mg vs. 400 + 100 mg BID combinations in HIV1-infected patients guided by therapeutic drug monitoring.

Wasmuth JC, Rodermann E, Voigt E, Vogel M, Lauenroth-Mai E, Jessen A, Burger D, Rockstroh JK. Wasmuth JC, et al. Eur J Med Res. 2007 Jul 26;12(7):289-94. Eur J Med Res. 2007. PMID: 17933700 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

146 results

Search Page